Glycemic control is essential for preventing major complications in individuals with type 2 diabetes (T2D) 1,2,3. Over the past decade, glycemic control has declined substantially in the United States ...
Type 1 diabetes is characterized by immune-associated destruction of insulin producing pancreatic beta cells resulting in a lifelong reliance on insulin replacement. However, cardiovascular disease ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
New data-driven approaches change how researchers evaluate experimental therapies in clinical trials. Among these, synthetic control arms use existing datasets to provide a flexible framework for ...
As cell and gene therapies (CGTs) continue to advance, they have unique developmental features that may require innovation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results